WGS

45.4607.68%
JR

Joshua Ruch

Independent Director

Mr. Joshua Ruch, MBA, is Director of GeneDx, Inc. from November 2017. Mr. Ruch serves as an Independent Director of GeneDx Holdings Corp. (formerly known as Sema4 Holdings Corp. and Mount Sinai Genomics, Inc.) since November 2017 and served as its Chairman of the Board from July 2021 until January 2022. He is also a Director at CloudPay Inc. Mr. Ruch served as a Member of the Advisory Board at New York City Investment Fund Manager, Inc., where he was responsible for the energy and infrastructure sector. A Co-Founder and Managing Partner at Rho Capital Partners, Inc. since 1981, he is also the Chairman and Chief Executive Officer of Vaal, Inc. Mr. Ruch has experience investing across all of Rho's active sectors. He serves as a Director of Code Ocean, Inc. and as an Advisor to Clean Urban Energy, Inc. Additionally, he is a Fund Advisor at CenterPoint Ventures. Prior to co-founding Rho Capital Partners and Rho Ventures in 1981, Mr. Ruch was an Investment Banker at Salomon Brothers and Halsey Stuart Inc. He co-founded Convey Computer Corporation in 2006 and has also served at Citigroup Global Markets Deutschland GmbH. Mr. Ruch served as the Chairman of Enerkem Inc. and is a Director of Clean Urban Energy, Inc. He serves as a Director of Ciris Energy, Inc., BP Biofuels Advanced Technology Inc. and Ipsum Networks, Inc. He has been a Director at Afina Energy Inc. since December 2007 and is a Member of the Advisory Board of Berenberg Bank. Mr. Ruch is also a Director at Laer and is a trustee of the Mount Sinai Health System, Carnegie Hall and the National Humanities Center. He is a member of the Board of Governors of the Technion – Israel Institute of Technology and serves on the Advisory Board of Joh. Berenberg, Gossler & Co. KG. He served as a Director at Sionex Corp and served as the Chairman of Ciris Energy, Inc. until August 16, 2013, while continuing to serve as its Director. His past directorships include Solicore, Inc., SolarBridge Technologies, Inc., Olympus Re Insurance Company, Ltd. and he has been a Director of Fractal Systems Inc. and Afina Energy, Inc. since November 2006. He has also served as a Director of Convey Computer Corporation, Celtro Communication (2012) Ltd., Vidyo, Inc. and CloudPay Solutions Limited. His previous roles include Director of BASF Enzymes LLC from June 20, 2007, to October 31, 2013 and Director of BrightVolt, Inc. He served as a Director of Verenium Corporation from June 20, 2007, to October 31, 2013 and held directorships at GenVec, Inc. from August 2003 to June 15, 2011, WiNetworks, Inc., Diacrin, Inc. from March 1998 to August 2003 and 3-Dimensional Pharmaceuticals, Inc. since March 1997, among others. Mr. Ruch's philanthropic activities include serving on the Board of Visitors of the Duke University School of Medicine and as a Trustee of Second Stage Theatre, Carnegie Hall and the National Humanities Center. He is also a Member of the Board of Governors of the Technion and the American Friends of Beit Issie Shapiro. His other current and previous Board seats include Human Genome Sciences, BC International, Parlo, Celunol and Tech Smart. Mr. Ruch has extensive private equity experience. He received an M.B.A. from Harvard Business School and a B.S. in Electrical Engineering from the Israel Institute of Technology and Clarkson University.

Positions